~~<i id='EEF901886B'><strike id='EEF901886B'><tt id='EEF901886B'><pre id='EEF901886B'></pre></tt></strike></i>~~

Home» comprehensive» entertainment

entertainment

author：knowledge 2025-10-04 08:46:05 Page View：7945

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Why health workers in Gaza are injured or die at high rates
Next article： At least 13 dead in Texas as scorching temps continue

focus

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

FDA seeking to stop procedures at two unregulated stem cell clinics

StemcellsSpencerPlatt/GettyImagesFederalofficialsmovedonWednesdaytostoptwoclinicsfromcontinuingtooff

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

A look at other Americans who have crossed into North Korea over the years

FILE-MatthewMiller,aU.S.citizen,sitsonthedockattheSupremeCourtduringhistrialinPyongyang,NorthKoreaon

WSS

entertainment

entertainment

explore

focus

A look at other Americans who have crossed into North Korea over the years